Divij Mathew
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 2%
- T-cell and B-cell Immunology
- Immunodeficiency and Autoimmune Disorders
- Immunotherapy and Immune Responses
Papers in
-
- SARS-CoV-2 and COVID-19 Research 12
- COVID-19 Clinical Research Studies 8
- Immunology 16
- T-cell and B-cell Immunology 8
- Immunodeficiency and Autoimmune Disorders 7
- Co-authors
- E. John Wherry (8 shared papers)Sasikanth Manne (3 shared papers)Josephine Ruth Giles (3 shared papers)Mohamed S. Abdel-Hakeem (2 shared papers)Raul Martin Torres (4 shared papers)Mohammed-Alkhatim Ali (1 shared paper)Jean‐Christophe Beltra (1 shared paper)Erietta Stelekati (1 shared paper)
- Journals
- Nature Immunology (4 papers)Cell (4 papers)Science Immunology (4 papers)Journal of Clinical Investigation (3 papers)Science (3 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Divij Mathew
44 papers receiving 6.6k citations
Divij Mathew's Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 4.1k
- Immunology 1.2k
- Oncology 821
- Pathology and Forensic Medicine 219
- Modeling and Simulation 52
Countries citing papers authored by Divij Mathew
This map shows the geographic impact of Divij Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Divij Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Divij Mathew more than expected).
Fields of papers citing papers by Divij Mathew
This network shows the impact of papers produced by Divij Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Divij Mathew. The network helps show where Divij Mathew may publish in the future.
Co-authors
The 25 scholars most cited alongside Divij Mathew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications Hit paper breakdown → | 2020 | 1226 |
| 2 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern Hit paper breakdown → | 2021 | 682 |
| 3 | 2020 | 594 | |
| 4 | Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination Hit paper breakdown → | 2021 | 514 |
| 5 | Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy Hit paper breakdown → | 2021 | 422 |
| 6 | CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Hit paper breakdown → | 2021 | 412 |
| 7 | Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination Hit paper breakdown → | 2021 | 392 |
| 8 | Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection Hit paper breakdown → | 2021 | 319 |
| 9 | 2021 | 182 | |
| 10 | 2022 | 177 | |
| 11 | 2021 | 172 | |
| 12 | 2015 | 170 | |
| 13 | Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine Hit paper breakdown → | 2022 | 163 |
| 14 | 2021 | 156 | |
| 15 | Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients Hit paper breakdown → | 2024 | 148 |
| 16 | Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer Hit paper breakdown → | 2024 | 122 |
| 17 | 2020 | 99 | |
| 18 | 2012 | 89 | |
| 19 | 2023 | 86 | |
| 20 | 2024 | 80 |
About Divij Mathew
Divij Mathew is a scholar working on Infectious Diseases, Immunology, Oncology, Molecular Biology and Hematology, having authored 46 papers that have together received 6.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), COVID-19 Clinical Research Studies (8 papers), T-cell and B-cell Immunology (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Single-cell and spatial transcriptomics (4 papers), Sphingolipid Metabolism and Signaling (2 papers) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Infectious Diseases (4.1k citations), Immunology (1.2k citations), Oncology (821 citations), Pathology and Forensic Medicine (219 citations) and Modeling and Simulation (52 citations). Divij Mathew has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include E. John Wherry, Sasikanth Manne, Josephine Ruth Giles, Mohamed S. Abdel-Hakeem, Raul Martin Torres, Mohammed-Alkhatim Ali, Jean‐Christophe Beltra, Erietta Stelekati, John L. Johnson and Kito Nzingha. Their work appears in journals such as Nature Immunology, Cell, Science Immunology, Journal of Clinical Investigation and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.